Europe’s medical devices industry saw a rise of 36.11% in deal activity during February 2022, when compared with the last 12-month average, led by AlbaCore Capital, Concord Health Partners and Hambro Perks’ $105m venture financing deal with MindMaze, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 49 medical devices industry deals worth $427.7m were announced for the region in February 2022, against the 12-month average of 36 deals.

Of all the deal types, venture financing saw most activity in February 2022 with 27 transactions, representing a 55.1% share for the region.

In second place was M&A with 13 deals, followed by private equity deals with nine transactions, respectively capturing a 26.5% and 18.4% share of the overall deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of deals, venture financing was the leading category in Europe’s medical devices industry with $370.8m, while M&A and private equity deals totalled $56.56m and $0.34m, respectively.

Europe medical devices industry deals in February 2022: Top deals

The top five medical devices deals accounted for 62.3% of the overall value during February 2022.

The combined value of the top five medical devices deals stood at $266.3m, against the overall value of $427.7m recorded for the month.

The top five medical devices industry deals of February 2022 tracked by GlobalData were:

1) AlbaCore Capital,Concord Health Partners and Hambro Perks $105m venture financing deal with MindMaze

2) The $55.61m acquisition of Laboratorios Herbitas by Prim

3) ABB Technology Ventures,Hummingbird Ventures,In-Q-Tel,Isomer Capital,Latitude Venture Partners and Octopus Ventures $50m venture financing deal with Automata Technologies

4) The $30m venture financing of Ada Health by Bertelsmann Investments,Farallon Capital Management and Red River West

5) Earlybird Venture Capital GmbHKG,Enterprise Ireland,LSP Health Economics Fund 2,MedFocus,Seroba Life Sciences Management and SV Health Investors $25.69m venture financing deal with Perfuze